Pablo Ramos

6PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersInnate immunityPacific Peoples theory of change models for healthMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 23, 2022
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination.

Miriam Echaide, Ibone Labiano, Marina Delgado

|Sep 09, 2022
How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells.

Anna Aiello, Mattia Emanuela Ligotti, Maider Garnica

|Sep 09, 2022
How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells.

Maider Garnica, Anna Aiello, Mattia Emanuela Ligotti

|Aug 26, 2022
Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer.

Hugo Arasanz, Ana Isabel Bocanegra, Idoia Morilla

|Aug 12, 2022
Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor.

Luisa Chocarro, Ana Bocanegra, Ester Blanco

|Apr 23, 2022
CAR-T Cells for the Treatment of Lung Cancer.

Luisa Chocarro, Hugo Arasanz, Leticia Fernández-Rubio

Pageof 1

Frequent Collaborators

6 joint publications

Hugo Arasanz

6 joint publications

Ester Blanco

6 joint publications

Ana Isabel Bocanegra

5 joint publications

Luisa Chocarro